These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Endothelial cells from pulmonary endarterectomy specimens possess a high angiogenic potential and express high levels of hepatocyte growth factor. Naito A; Sakao S; Lang IM; Voelkel NF; Jujo T; Ishida K; Sugiura T; Matsumiya G; Yoshino I; Tanabe N; Tatsumi K BMC Pulm Med; 2018 Dec; 18(1):197. PubMed ID: 30594174 [TBL] [Abstract][Full Text] [Related]
5. Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension. Quarck R; Wynants M; Verbeken E; Meyns B; Delcroix M Eur Respir J; 2015 Aug; 46(2):431-43. PubMed ID: 26113681 [TBL] [Abstract][Full Text] [Related]
6. From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension. Bochenek ML; Rosinus NS; Lankeit M; Hobohm L; Bremmer F; Schütz E; Klok FA; Horke S; Wiedenroth CB; Münzel T; Lang IM; Mayer E; Konstantinides S; Schäfer K Thromb Haemost; 2017 Apr; 117(4):769-783. PubMed ID: 28150849 [TBL] [Abstract][Full Text] [Related]
7. Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism. Naito A; Tanabe N; Jujo T; Shigeta A; Sugiura T; Sakao S; Ishida K; Tatsumi K PLoS One; 2014; 9(11):e113086. PubMed ID: 25412085 [TBL] [Abstract][Full Text] [Related]
8. Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension. Lankeit M; Dellas C; Panzenböck A; Skoro-Sajer N; Bonderman D; Olschewski M; Schäfer K; Puls M; Konstantinides S; Lang IM Eur Respir J; 2008 May; 31(5):1024-9. PubMed ID: 18256058 [TBL] [Abstract][Full Text] [Related]
9. Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension. Khirfan G; Tejwani V; Wang X; Li M; DiDonato J; Dweik RA; Smedira N; Heresi GA PLoS One; 2018; 13(5):e0197700. PubMed ID: 29813091 [TBL] [Abstract][Full Text] [Related]
10. Potential Involvement of Osteopontin in Inflammatory and Fibrotic Processes in Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension. Kölmel S; Hobohm L; Käberich A; Krieg VJ; Bochenek ML; Wenzel P; Wiedenroth CB; Liebetrau C; Hasenfuß G; Mayer E; Konstantinides SV; Schäfer K; Guth S; Lankeit M Thromb Haemost; 2019 Aug; 119(8):1332-1346. PubMed ID: 31183846 [TBL] [Abstract][Full Text] [Related]
11. The role of mononuclear cell tissue factor and inflammatory cytokines in patients with chronic thromboembolic pulmonary hypertension. Yang M; Deng C; Wu D; Zhong Z; Lv X; Huang Z; Lian N; Liu K; Zhang Q J Thromb Thrombolysis; 2016 Jul; 42(1):38-45. PubMed ID: 26667361 [TBL] [Abstract][Full Text] [Related]
12. Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension. Jujo T; Tanabe N; Sakao S; Ishibashi-Ueda H; Ishida K; Naito A; Kato F; Takeuchi T; Sekine A; Nishimura R; Sugiura T; Shigeta A; Masuda M; Tatsumi K PLoS One; 2016; 11(8):e0161827. PubMed ID: 27571267 [TBL] [Abstract][Full Text] [Related]
13. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Bonderman D; Skoro-Sajer N; Jakowitsch J; Adlbrecht C; Dunkler D; Taghavi S; Klepetko W; Kneussl M; Lang IM Circulation; 2007 Apr; 115(16):2153-8. PubMed ID: 17420352 [TBL] [Abstract][Full Text] [Related]
14. Histopathological multiple recanalized lesion is critical element of outcome after pulmonary thromboendarterectomy. Hosokawa K; Ishibashi-Ueda H; Kishi T; Nakanishi N; Kyotani S; Ogino H Int Heart J; 2011; 52(6):377-81. PubMed ID: 22188712 [TBL] [Abstract][Full Text] [Related]
15. Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension. Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Nakanishi N Chest; 2003 Oct; 124(4):1305-11. PubMed ID: 14555559 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary Endarterectomy Surgery for Chronic Thromboembolic Pulmonary Hypertension: A Small-Volume National Referral Center Experience. Segel MJ; Kogan A; Preissman S; Agmon-Levin N; Lubetsky A; Fefer P; Schaefers HJ; Raanani E Isr Med Assoc J; 2019 Aug; 21(8):528-531. PubMed ID: 31474014 [TBL] [Abstract][Full Text] [Related]
17. Predictors of infection after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension. Maruna P; Kunstyr J; Plocova KM; Mlejnsky F; Hubacek J; Klein AA; Lindner J Eur J Cardiothorac Surg; 2011 Feb; 39(2):195-200. PubMed ID: 20615721 [TBL] [Abstract][Full Text] [Related]
18. Red cell distribution width: a new predictor for chronic thromboembolic pulmonary hypertension after pulmonary embolism. Abul Y; Ozsu S; Korkmaz A; Bulbul Y; Orem A; Ozlu T Chron Respir Dis; 2014 May; 11(2):73-81. PubMed ID: 24595892 [TBL] [Abstract][Full Text] [Related]
19. Coagulation-Fibrinolysis System and Postoperative Outcomes of Patients With Chronic Thromboembolic Pulmonary Hypertension. Kato F; Tanabe N; Ishida K; Suda R; Sekine A; Nishimura R; Jujo T; Sugiura T; Sakao S; Tatsumi K Circ J; 2016; 80(4):970-9. PubMed ID: 26888150 [TBL] [Abstract][Full Text] [Related]
20. [Chronic thromboembolic pulmonary hypertension: Time delay from onset of symtoms to diagnosis and clinical condition at diagnosis]. Held M; Grün M; Holl R; Walter F; Schäfers HJ; Graeter T; Wilkens H; Jany B Dtsch Med Wochenschr; 2014 Aug; 139(33):1647-52. PubMed ID: 25093951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]